Inhaled nitric oxide: can it serve as a savior for COVID-19 and related respiratory and cardiovascular diseases?
Yifan Zhao, Cheng Li, Shuai Zhang, Jiayu Cheng, Yucheng Liu, Xiaorong Han, Yinghui Wang, Yonggang Wang
Frontiers in Microbiology, doi:10.3389/fmicb.2023.1277552
Nitric oxide (NO), as an important gaseous medium, plays a pivotal role in the human body, such as maintaining vascular homeostasis, regulating immuneinflammatory responses, inhibiting platelet aggregation, and inhibiting leukocyte adhesion. In recent years, the rapid prevalence of coronavirus disease 2019 (COVID-19) has greatly affected the daily lives and physical and mental health of people all over the world, and the therapeutic efficacy and resuscitation strategies for critically ill patients need to be further improved and perfected. Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator, and some studies have demonstrated its potential therapeutic use for COVID-19, severe respiratory distress syndrome, pulmonary infections, and pulmonary hypertension. In this article, we describe the biochemistry and basic characteristics of NO and discuss whether iNO can act as a "savior" for COVID-19 and related respiratory and cardiovascular disorders to exert a potent clinical protective effect.
Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Adhikari, Burns, Friedrich, Granton, Cook et al., Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis, BMJ,
doi:10.1136/bmj.39139.716794.55Adusumilli, Zhang, Friedman, Friedman, Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19, Nitric Oxide,
doi:10.1016/j.niox.2020.07.003Afshari, Brok, Møller, Wetterslev, Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis, Anesth. Analg,
doi:10.1213/ANE.0b013e31820bd185Akaberi, Krambrich, Ling, Luni, Hedenstierna et al., Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro, Redox Biol,
doi:10.1016/j.redox.2020.101734Al Sulaiman, Korayem, Altebainawi, Al Harbi, Alissa et al., Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study, Crit. Care,
doi:10.1186/s13054-022-04158-yArcher, Sharp, Weir, Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema: therapeutic implications, Circulation,
doi:10.1161/circulationaha.120.047915Arnold, Mittal, Katsuki, Murad, Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations, Proc. Natl. Acad. Sci. U. S. A,
doi:10.1073/pnas.74.8.3203Ataei Ataabadi, Golshiri, Jüttner, Krenning, Danser et al., Nitric oxide-cGMP signaling in hypertension: current and future options for pharmacotherapy, Hypertension,
doi:10.1161/hypertensionaha.120.15856Betancor, Olaguibel, Sastre, The discrepant role of fractional exhaled nitric oxide in SARS-CoV-2 infection, J. Investig. Allergol. Clin. Immunol,
doi:10.18176/jiaci.0842Betancor, Valverde-Mongue, Gomez-Lopez, Barroso, Ruete et al., Evaluation of fractional exhaled nitric oxide during SARS-CoV-2 infection, J. Investig. Allergol. Clin. Immunol,
doi:10.18176/jiaci.0762Bonizzoli, Lazzeri, Cianchi, Guetti, Fulceri et al., Effects of rescue inhaled nitric oxide on right ventricle and pulmonary circulation in severe COVID-related acute respiratory distress syndrome, J. Crit. Care,
doi:10.1016/j.jcrc.2022.153987Cespuglio, Strekalova, Spencer, Román, Reis et al., SARS-CoV-2 infection and sleep disturbances: nitric oxide involvement and therapeutic opportunity, Sleep,
doi:10.1093/sleep/zsab009Chambers, Tunnicliffe, Ayres, Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations, Thorax,
doi:10.1136/thx.53.8.677Chen, Klein, Garibaldi, Li, Wu et al., Aging in COVID-19: vulnerability, immunity and intervention, Ageing Res. Rev,
doi:10.1016/j.arr.2020.101205Cinelli, Do, Miley, Silverman, Inducible nitric oxide synthase: regulation, structure, and inhibition, Med. Res. Rev,
doi:10.1002/med.21599Demoncheaux, Higenbottam, Kiely, Wong, Wharton et al., Decreased whole body endogenous nitric oxide production in patients with primary pulmonary hypertension, J. Vasc. Res,
doi:10.1159/000083502Deppisch, Herrmann, Graepler-Mainka, Wirtz, Heyder et al., Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study, Infection,
doi:10.1007/s15010-016-0879-xDominic, Ahmad, Bhandari, Pardue, Solorzano et al., Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19, Redox Biol,
doi:10.1016/j.redox.2021.101982Feng, Yang, Wen, Liu, Liu et al., Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension, ESC Heart Fail,
doi:10.1002/ehf2.13023Flume, Garcia, Wilson, Steed, Dorman, Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection, Respir. Med,
doi:10.1016/j.rmed.2022.107069Frostell, Hedenstierna, Nitric oxide and COVID-19: dose, timing and how to administer it might be crucial, Acta Anaesthesiol. Scand,
doi:10.1111/aas.13788Garfield, Mcfadyen, Briar, Bleakley, Vlachou et al., Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia, Br. J. Anaesth,
doi:10.1016/j.bja.2020.11.006Garufi, Carbognin, Orlandi, Tortora, Bria, Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: the unsolved paradox behind the evidence, Eur. J. Intern. Med,
doi:10.1016/j.ejim.2020.04.042Gebistorf, Karam, Wetterslev, Afshari, Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults, Cochrane Database Syst. Rev,
doi:10.1002/14651858.CD002787.pub3Ghaffari, Miller, Mcmullin, Ghahary, Potential application of gaseous nitric oxide as a topical antimicrobial agent, Nitric Oxide,
doi:10.1016/j.niox.2005.08.003Giaid, Saleh, Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension, N. Engl. J. Med,
doi:10.1056/nejm199507273330403Goldbart, Lavie, Lubetzky, Pillar, Landau et al., Inhaled nitric oxide for the treatment of acute bronchiolitis: a multicenter randomized controlled clinical trial to evaluate dose response, Ann. Am. Thorac. Soc,
doi:10.1513/AnnalsATS.202103-348OCGoldberg, Mazur, Kalra, Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies, Cardiovasc Diagn Ther,
doi:10.21037/cdt.2017.04.11Grześk, Witczyńska, Węglarz, Wołowiec, Nowaczyk et al., Soluble guanylyl cyclase activators-promising therapeutic option in the pharmacotherapy of heart failure and pulmonary hypertension, Molecules,
doi:10.3390/molecules28020861Guida, Carriero, Bertolini, Pizzimenti, Heffler et al., Exhaled nitric oxide in asthma: from diagnosis to management, Curr. Opin. Allergy Clin. Immunol,
doi:10.1097/aci.0000000000000877Guimarães, Rossini, Lameu, Implications of SARS-Cov-2 infection on eNOS and iNOS activity: consequences for the respiratory and vascular systems, Nitric Oxide,
doi:10.1016/j.niox.2021.04.003Hedenstierna, Chen, Hedenstierna, Lieberman, Fine, Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19, Nitric Oxide,
doi:10.1016/j.niox.2020.06.005Ishii, Hatano, Maki, Minatsuki, Saito et al., Prognostic value of follow-up vasoreactivity test in pulmonary arterial hypertension, J. Cardiol,
doi:10.1016/j.jjcc.2023.01.005Karki, Sharma, Tuladhar, Williams, Zalduondo et al., Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes, Cells,
doi:10.1016/j.cell.2020.11.025Kerget, Araz, Akgün, The role of exhaled nitric oxide (FeNO) in the evaluation of lung parenchymal involvement in COVID-19 patients, Intern. Emerg. Med,
doi:10.1007/s11739-022-03035-4Keshavarz, Kadry, Alobaida, Ahsan, Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension, Expert Opin. Drug Deliv,
doi:10.1080/17425247.2020.1729119Lior, Yatzkan, Brami, Yogev, Riff et al., Fractional exhaled nitric oxide (FeNO) level as a predictor of COVID-19 disease severity, Nitric Oxide,
doi:10.1016/j.niox.2022.05.002Longobardo, Montanari, Shulman, Benhalim, Singer et al., Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome, Br. J. Anaesth,
doi:10.1016/j.bja.2020.10.011Lotz, Muellenbach, Meybohm, Mutlak, Lepper et al., Effects of inhaled nitric oxide in COVID-19-induced ARDS-is it worthwhile?, Acta Anaesthesiol. Scand,
doi:10.1111/aas.13757Ma, Li, Yang, Liu, Zhang et al., Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions, Signal Transduct. Target. Ther,
doi:10.1038/s41392-023-01430-7Malhotra, Hess, Lewis, Bloch, Waxman et al., Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension, Pulm Circ,
doi:10.4103/2045-8932.83449Maniscalco, Ambrosino, Poto, Fuschillo, Poto et al., Can FeNO be a biomarker in the post-COVID-19 patients monitoring?, Respir. Med,
doi:10.1016/j.rmed.2022.106745Mekontso Dessap, Papazian, Schaller, Nseir, Megarbane et al., Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes, Ann. Intensive Care,
doi:10.1186/s13613-023-01150-9Michaelsen, Ribeiro, Brambate, Ali, Wang et al., A novel pre-clinical strategy to deliver antimicrobial doses of inhaled nitric oxide, PloS One,
doi:10.1371/journal.pone.0258368Miller, Hergott, Rohan, Arsenault-Mehta, Döring et al., Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia, J. Cyst. Fibros,
doi:10.1016/j.jcf.2013.01.008Miller, Miller, Mcmullin, Regev, Serghides et al., A phase I clinical study of inhaled nitric oxide in healthy adults, J. Cyst. Fibros,
doi:10.1016/j.jcf.2012.01.003Montiel, Lobysheva, Gérard, Vermeersch, Perez-Morga et al., Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients, EBioMedicine,
doi:10.1016/j.ebiom.2022.103893Mortaz, Malkmohammad, Jamaati, Naghan, Hashemian et al., Silent hypoxia: higher NO in red blood cells of COVID-19 patients, BMC Pulm. Med,
doi:10.1186/s12890-020-01310-8Nakane, Esaki, Ueda, Honda, Okabayashi, Inhaled nitric oxide improves pulmonary hypertension and organ functions after adult heart valve surgeries, Gen. Thorac. Cardiovasc. Surg,
doi:10.1007/s11748-021-01651-zNasyrova, Moskaleva, Vaiman, Shnayder, Blatt et al., Genetic factors of nitric Oxide's system in Psychoneurologic disorders, Int. J. Mol. Sci,
doi:10.3390/ijms21051604Nathan, Flaherty, Glassberg, Raghu, Swigris et al., A randomized, double-blind, placebo-controlled study of pulsed, inhaled nitric oxide in subjects at risk of pulmonary hypertension associated with pulmonary fibrosis, Chest,
doi:10.1016/j.chest.2020.02.016Nogueira, Minnion, Clark, Dyson, Tanus-Santos et al., On the origin of nitrosylated hemoglobin in COVID-19: endothelial NO capture or redox conversion of nitrite?: experimental results and a cautionary note on challenges in translational research, Redox Biol,
doi:10.1016/j.redox.2022.102362Papadopoulos, Papadopoulou, Aw, Live to die another day: novel insights may explain the pathophysiology behind smoker's paradox in SARS-CoV-2 infection, Mol. Cell. Biochem,
doi:10.1007/s11010-023-04681-8Parikh, Wilson, Weinberg, Gavin, Murphy et al., Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients, Ther. Adv. Respir. Dis,
doi:10.1177/1753466620933510Redaelli, Magliocca, Malhotra, Ristagno, Citerio et al., Nitric oxide: clinical applications in critically ill patients, Nitric Oxide,
doi:10.1016/j.niox.2022.01.007Redaelli, Pozzi, Giani, Magliocca, Fumagalli et al., Inhaled nitric oxide in acute respiratory distress syndrome subsets: rationale and clinical applications, J. Aerosol Med. Pulm. Drug Deliv,
doi:10.1089/jamp.2022.0058Rousseaud, Prot, Loriere, Katz, Ramirez-Gil et al., Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitro, Nitric Oxide,
doi:10.1016/j.niox.2023.01.004Russo, Barale, Melchionda, Penna, Pagliaro, Platelets and Cardioprotection: the role of nitric oxide and carbon oxide, Int. J. Mol. Sci,
doi:10.3390/ijms24076107Safaee Fakhr, Di Fenza, Gianni, Wiegand, Miyazaki et al., Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia, Nitric Oxide,
doi:10.1016/j.niox.2021.08.003Safaee Fakhr, Wiegand, Pinciroli, Gianni, Morais et al., High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19), Obstet. Gynecol,
doi:10.1097/aog.0000000000004128Sardo, Osawa, Finco, Gomes Galas, De Almeida et al., Nitric oxide in cardiac surgery: a Meta-analysis of randomized controlled trials, J. Cardiothorac. Vasc. Anesth,
doi:10.1053/j.jvca.2018.02.003Sharma, Patel, Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states, Expert Opin. Ther. Targets,
doi:10.1080/14728222.2017.1265505Signori, Magliocca, Hayashida, Graw, Malhotra et al., Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases, Intensive Care Med. Exp,
doi:10.1186/s40635-022-00455-6Sorbo, Michaelsen, Ali, Wang, Ribeiro et al., High doses of inhaled nitric oxide as an innovative antimicrobial strategy for lung infections, Biomedicine,
doi:10.3390/biomedicines10071525Stefano, Esch, Kream, Potential Immunoregulatory and antiviral/SARS-CoV-2 activities of nitric oxide, Med. Sci. Monit,
doi:10.12659/msm.925679Stratton, Tang, Lu, Pathogenesis-directed therapy of 2019 novel coronavirus disease, J. Med. Virol,
doi:10.1002/jmv.26610Tooba, Almoushref, Tonelli, Is there value in repeating inhaled nitric oxide Vasoreactivity tests in patients with pulmonary arterial hypertension?, Lung,
doi:10.1007/s00408-019-00318-0Triposkiadis, Xanthopoulos, Skoularigis, Starling, Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure, Heart Fail. Rev,
doi:10.1007/s10741-022-10239-5Wang, Yu, Ochani, Amella, Tanovic et al., Nicotinic acetylcholine receptor alpha 7 subunit is an essential regulator of inflammation, Nature,
doi:10.1038/nature01339Wiegand, Traeger, Nguyen, Rouillard, Fischbach et al., Antimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia, Redox Biol,
doi:10.1016/j.redox.2020.101826Winchester, John, Jabbar, John, Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection, J. Infect,
doi:10.1016/j.jinf.2021.05.009Yao, Zou, Cui, Quan, Gao et al., Recent advances in strategies to combat bacterial drug resistance: antimicrobial materials and drug delivery systems, Pharmaceutics,
doi:10.3390/pharmaceutics15041188Zhao, None, Frontiers in Microbiology
Zhao, None, Frontiers in Microbiology
